A 32-year-old woman with community-acquired pneumonia is started on amoxicillin-clavulanate. After 48 hours of therapy, she develops a diffuse maculopapular rash sparing the palms and soles, with fever (38.5°C) and mild hepatic transaminitis (ALT 120 U/L). She denies respiratory distress or angioedema. What is the most appropriate next step in management?

Explanation

## Clinical Presentation Analysis The patient presents with a **delayed hypersensitivity reaction (Type IV)** to beta-lactam antibiotics, evidenced by: - Maculopapular rash appearing 48 hours after drug initiation - Systemic symptoms (fever, hepatitis) - Absence of anaphylaxis or angioedema **Key Point:** This is **amoxicillin rash** — a drug reaction that mandates **immediate discontinuation** of the offending beta-lactam. Continuing the drug risks progression to severe cutaneous adverse reactions (SCAR) such as DRESS syndrome or Stevens-Johnson syndrome. ## Management Algorithm ```mermaid flowchart TD A[Beta-lactam rash + fever + hepatitis]:::outcome --> B{Anaphylaxis or angioedema?}:::decision B -->|Yes| C[Stop immediately, give epinephrine]:::urgent B -->|No| D[Delayed hypersensitivity reaction]:::outcome D --> E[Discontinue beta-lactam]:::action E --> F[Switch to non-cross-reactive agent]:::action F --> G[Fluoroquinolone or macrolide]:::action G --> H[Monitor for resolution]:::action ``` ## Why Fluoroquinolone? **High-Yield:** Respiratory fluoroquinolones (levofloxacin, moxifloxacin) are: - **Non-cross-reactive** with beta-lactams (different mechanism and structure) - **Excellent lung penetration** for pneumonia - **Oral or IV formulations** available - **No structural homology** to penicillins or cephalosporins **Clinical Pearl:** Cross-reactivity between penicillins and cephalosporins is ~1–3% in non-anaphylaxis reactions; however, **amoxicillin-clavulanate rash is often due to clavulanic acid**, which has a different epitope — switching to another beta-lactam is still risky. ## Why NOT the Other Options? | Option | Why Incorrect | |--------|---------------| | Continue + antihistamine | Antihistamines do NOT prevent progression of Type IV reactions; continuing the drug risks SCAR (DRESS, SJS). | | Skin prick testing | Prick tests are unreliable for delayed reactions; they assess immediate hypersensitivity. Continuing is unsafe. | | Observe 24 hours | Delayed hypersensitivity reactions can progress rapidly to severe forms (DRESS, SJS) within 24–48 hours. Observation without drug cessation is contraindicated. | **Warning:** Do NOT confuse amoxicillin rash (benign, self-limited in EBV-negative patients) with **drug reaction with eosinophilia and systemic symptoms (DRESS)**. The presence of fever + hepatitis + rash suggests possible DRESS evolution — discontinuation is urgent.